Hong Kong Stock Market News | Fosun Pharma (00013.HK) surges by over 5%, application for new drug using Pembrolizumab and Xinciilimab combination therapy has been accepted

According to the Wisdom Financial APP, Hutchison Medicine (00013.HK) is currently up more than 5%, as of the time of writing, it is up 5.27%, trading at 24.95 Hong Kong dollars, with a turnover of 4868.61 million Hong Kong dollars.